Blood Donors Hemovigilance in Public Sector Tertiary Care Hospitals of Peshawar: Blood Donors Hemovigilance in Public Sector

Safia  Nawaz; Ayaz Ayub; Bilal Ahmad; Tahira  Nawaz

doi:10.54393/pjhs.v4i08.959

Authors

Safia Nawaz Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan
Ayaz Ayub Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan
Bilal Ahmad Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan
Tahira Nawaz Department of Biochemistry, University of Peshawar, Peshawar, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i08.959

Keywords:

Blood Donor, Hemovigilance, Blood Bank, Adverse Reactions, Donor Safety

Abstract

Hemovigilance of blood donors is an integral part of blood transfusion system, conferring to lessen the blood donation complications and enhancing the safety of blood donors. Objective: To determine the prevalence, severity, and associated factors of acute hemovigilance reactions in the blood donors of public sector tertiary care hospital bank banks in Peshawar. Methods: A multi-centered, cross-sectional approach was applied on blood donors` population selected via random proportionate sampling, visiting 6 Public sector tertiary care hospitals in Peshawar. Adverse reactions were reported on national guidelines reporting form during and after the blood donation. Results: Out of 420 blood donors selected via random proportionate sampling of total blood donors` population, prevalence of acute adverse hemovigilance reaction was 8.57% while no adverse reactions occurred in 91.43% of the blood donors. The most frequent hemovigilance reaction was vasovagal reactions (5.2%). All the reactions were of mild to moderate severity with no life threatening hemovigilance reactions. Conclusions: The overall prevalence rate was 8.57% of all healthy blood donors` which strengthens the fact that adverse reactions are avoidable complication of blood donations among the voluntary and replacement blood donors, and can be prevented with centralized hemovigilance data base for a sustainable base of voluntary blood donors.

References

Ayob Y. Hemovigilance in developing countries. Biologicals. 2010 Jan; 38(1): 91-6. doi: 10.1016/j.biologicals.2009.10.002. DOI: https://doi.org/10.1016/j.biologicals.2009.10.002

Mukherjee S and Maiti R. Haemovigilance: a current update in Indian perspective. Journal of Clinical and Diagnostic Research: JCDR. 2016 Nov; 10(11): EE05. DOI: https://doi.org/10.7860/JCDR/2016/21029.8868

Agnihotri N and Agnihotri A. Active hemovigilance significantly improves reporting of acute non-infectious adverse reactions to blood transfusion. Indian Journal of Hematology and Blood Transfusion. 2016 Sep; 32: 335-42. doi: 10.1007/s12288-015-0568-4. DOI: https://doi.org/10.1007/s12288-015-0568-4

Shabber HI, Ishtiaq M, Waheed U, Zaheer HA. Adverse Reactions in Blood Donors in a Tertiary Care Teaching Hospital Blood Bank of Islamabad, Pakistan. Journal of Islamabad Medical & Dental College (JIMDC). 2016 Sep; 5(2): 81-3.

Zaheer HA and Waheed U. Blood safety system reforms in Pakistan. Blood Transfusion. 2014 Oct; 12(4): 452. doi: 10.2450/2014.0253-13.

Bou Assi T, Haddad A, Haddad L, Garraud O. Can a decentralized blood supply system reach 100% voluntary nonremunerated donation?. The International Journal of Health Planning and Management. 2018 Oct; 33(4): e883-91. doi: 10.1002/hpm.2576. DOI: https://doi.org/10.1002/hpm.2576

Waheed U, Ahmed S, e Saba N, Wazeer A. Haemovigilance as a quality indicator in transfusion medicine: Pakistan’s perspective. Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University. 2020 Apr; 16(1): 46-51. doi: 10.48036/apims.v16i1.353.

Faber JC. Worldwide overview of existing haemovigilance systems. Transfusion and Apheresis Science. 2004 Oct; 31(2): 99-110. doi: 0.1016/j.transci.2004.07.004. DOI: https://doi.org/10.1016/j.transci.2004.07.004

The Khyber Pakhtunkhwa blood transfusion safety authority act. [Last Cited: 27 Oct 2016]. Available at: http://www.pakp.gov.pk/2013/acts/the-khyber-pakhtunkhwa-blood-transfusion-safety-authority-act2016/.

Wood EM, Ang AL, Bisht A, Bolton‐Maggs PH, Bokhorst AG, Flesland O, et al. International haemovigilance: what have we learned and what do we need to do next?. Transfusion Medicine. 2019 Aug; 29(4): 221-30. doi: 10.1111/tme.12582. DOI: https://doi.org/10.1111/tme.12582

Newman BH. Donor reactions and injuries from whole blood donation. Transfusion Medicine Reviews. 1997 Jan; 11(1): 64-75. doi: 10.1016/S0887-7963(97)80011-9. DOI: https://doi.org/10.1016/S0887-7963(97)80011-9

Philip J, Sarkar RS, Pathak A. Adverse events associated with apheresis procedures: Incidence and relative frequency. Asian Journal of Transfusion Science. 2013 Jan; 7(1): 37. doi: 10.4103/0973-6247.106730. DOI: https://doi.org/10.4103/0973-6247.106730

Goldman M, Osmond L, Yi QL, Cameron‐Choi K, O'Brien SF. Frequency and risk factors for donor reactions in an anonymous blood donor survey. Transfusion. 2013 Sep; 53(9): 1979-84. doi: 10.1111/trf.12011. DOI: https://doi.org/10.1111/trf.12011

Wiersum-Osselton JC, Brand A, Veldhuizen I, van der Bom JG, de Kort W. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return. Blood Transfusion. 2014 Jan; 12(Suppl 1): s28. doi: 10.2450/2013.0262-12.

Sahu S and Verma A. Adverse events related to blood transfusion. Indian journal of anaesthesia. 2014 Sep; 58(5): 543. doi: 10.4103/0019-5049.144650. DOI: https://doi.org/10.4103/0019-5049.144650

Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, Wiersum‐Osselton JC. International validation of harmonized definitions for complications of blood donations. Transfusion. 2018 Nov; 58(11): 2589-95. doi: 10.1111/trf.14948. DOI: https://doi.org/10.1111/trf.14948

Zeiler T, Lander‐Kox J, Eichler H, Alt T, Bux J. The safety of blood donation by elderly blood donors. Vox Sanguinis. 2011 Nov; 101(4): 313-9. doi: 10.1111/j.1423-0410.2011.01492.x. DOI: https://doi.org/10.1111/j.1423-0410.2011.01492.x

Newman BH, Pichette S, Pichette D, Dzaka E. Adverse effects in blood donors after whole‐blood donation: a study of 1000 blood donors interviewed 3 weeks after whole‐blood donation. Transfusion. 2003 May; 43(5): 598-603. doi: 10.1046/j.1537-2995.2003.00368.x. DOI: https://doi.org/10.1046/j.1537-2995.2003.00368.x

Inaba S, Takanashi M, Matsuzaki K, Ono Y, Nakajima K, Shibata R, et al. Analysis of a questionnaire on adverse reactions to blood donation in Japan. Transfusion and Apheresis Science. 2013 Feb; 48(1): 21-34. doi: 10.1016/j.transci.2012.07.012. DOI: https://doi.org/10.1016/j.transci.2012.07.012

Charoonruangrit U. Thailand experience in implementing haemovigilance. Blood Transfus. 2013; 23(1): 53-60.

Kamel H, Tomasulo P, Bravo M, Wiltbank T, Cusick R, James RC, et al. Blood donors and blood collection: delayed adverse reactions to blood donation. Transfusion. 2010 Mar; 50(3): 556-65. doi: 10.1111/j.1537-2995.2009.02397.x. DOI: https://doi.org/10.1111/j.1537-2995.2009.02397.x

Agnihotri N, Marwaha N, Sharma RR. Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India. Asian Journal of Transfusion Science. 2012 Jul; 6(2): 155. doi: 10.4103/0973-6247.98922. DOI: https://doi.org/10.4103/0973-6247.98922

Patidar GK, Sharma RR, Marwaha N. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India. Transfusion and Apheresis Science. 2013 Oct; 49(2): 244-8. doi: 10.1016/j.transci.2013.06.003. DOI: https://doi.org/10.1016/j.transci.2013.06.003

Mahbub-ul-Alam M, Hyder MS, Khan MB, Islam MA. Adverse donor reaction during and immediately after Venesection. The Journal of Teachers Association RMC. Rajshahi. 2007 Aug; 20(1): 39-47. doi: 10.3329/TAJ.V20I1.3088. DOI: https://doi.org/10.3329/taj.v20i1.3088

Sultan S, Baig MA, Irfan SM, Ahmed SI, Hasan SF. Adverse reactions in allogeneic blood donors: A tertiary care experience from a developing country. Oman Medical Journal. 2016 Mar; 31(2): 124. doi: 10.5001/omj.2016.24. DOI: https://doi.org/10.5001/omj.2016.24

Rohra DK, Juriasinghani V, Rai K, Azam SI. Prevalence of immediate vasovagal reaction in blood donors visiting two blood banks of Karachi. Transfusion Medicine. 2010 Jun; 20(3): 129-33. doi: 10.1111/j.1365-3148.2009.00984.x. DOI: https://doi.org/10.1111/j.1365-3148.2009.00984.x

Amanat ST, Shakoor HA, Raza M, Khan N, Rauf A. Clinical indications and adverse reactions of platelet apheresis. Journal of College of Physicians and Surgeons Pakistan. 2015 Jun; 25(6): 403-6.

Shabber HI, Ishtiaq M, Waheed U, Zaheer HA. Adverse Reactions in Blood Donors in a Tertiary Care Teaching Hospital Blood Bank of Islamabad, Pakistan. Journal of Islamabad Medical & Dental College (JIMDC). 2016; 5(2): 81-3.

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013 Nov; 310(20): 2191-4. doi: 10.1001/jama.2013.281053. DOI: https://doi.org/10.1001/jama.2013.281053

Ebihara A. World medical association declaration of Helsinki. Japanese Pharmacology and Therapeutics. 2000; 28(12): 983-8.

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. The Journal of the American College of Dentists. 2014. 81(3):14-8.

Jain A and Kaur R. Hemovigilance and blood safety. Asian Journal of Transfusion Science. 2012 Jul; 6(2): 137. DOI: https://doi.org/10.4103/0973-6247.98911

Edwards L, McIntyre D, Carroll D, Ring C, France CR, Martin U. Effects of artificial and natural baroreceptor stimulation on nociceptive responding and pain. Psychophysiology. 2003 Sep; 40(5): 762-9. doi: 10.1111/1469-8986.00076. DOI: https://doi.org/10.1111/1469-8986.00076

Assarian Z, Abed Haghighi B, Javadi I, Fotouhi A, Seighali F, Akbari N. Risk factors for vasovagal reactions during blood donation. Scientific Journal of Iran Blood Transfus Organ. 2011 Jan; 7(4): 221-6.

AuBuchon JP and Popovsky MA. The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion. 1991 Jul; 31(6): 513-7. doi: 10.1046/j.1537-2995.1991.31691306248.x. DOI: https://doi.org/10.1046/j.1537-2995.1991.31691306248.x

Kasprisin DO, Glynn SH, Taylor F, Miller KA. Moderate and severe reactions in blood donors. Transfusion. 1992 Jan; 32(1): 23-6. doi: 10.1046/j.1537-2995.1992.32192116426.x. DOI: https://doi.org/10.1046/j.1537-2995.1992.32192116426.x

Trouern‐Trend JJ, Cable RG, Badon SJ, Newman BH, Popovsky MA. A case‐controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion. 1999 Mar; 39(3): 316-20. doi: 10.1046/j.1537-2995.1999.39399219291.x. DOI: https://doi.org/10.1046/j.1537-2995.1999.39399219291.x

Bani M and Giussani B. Gender differences in giving blood: a review of the literature. Blood Transfusion. 2010 Oct; 8(4): 278. doi: 10.2450/2010.0156-09.

Irfan SM, Uddin J, Zaheer HA, Sultan S, Baig A. Trends in transfusion transmitted infections among replacement blood donors in Karachi, Pakistan. Turkish Journal of Haematology. 2013 Jun; 30(2): 163-7 doi: 10.4274/Tjh.2012.0132. DOI: https://doi.org/10.4274/Tjh.2012.0132

Newman BH and Waxman DA. Blood donation‐related neurologic needle injury: evaluation of 2 years' worth of data from a large blood center. Transfusion. 1996 Mar; 36(3): 213-5. doi: 10.1046/j.1537-2995.1996.36396182137.x. DOI: https://doi.org/10.1046/j.1537-2995.1996.36396182137.x